+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

RYTARY Drug Profile, 2019

  • ID: 4727221
  • Report
  • October 2020
  • Region: Global
  • 44 pages
  • thinkBiotech LLC
1 of 4

FEATURED COMPANIES

  • Abi Chem
  • Impax Specialty Pharma
  • Novoseek
  • MORE
RYTARY Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.

The report focuses on RYTARY and covers the following critical aspects of this drug:
  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
About the Researcher

The researcher is a provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abi Chem
  • Impax Specialty Pharma
  • Novoseek
  • MORE
  • Profile for RYTARY
  • US Patents
  • US Regulatory Exclusivity
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • International (ex US) Patents
  • Drug Prices - Average Pharmacy Cost
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Impax Specialty Pharma
  • Novoseek
  • Abi Chem
Note: Product cover images may vary from those shown
Adroll
adroll